-
Signature
-
/s/ Benjamin Waters, Attorney-in-Fact
-
Stock symbol
-
GBIO
-
Transactions as of
-
Jan 2, 2024
-
Transactions value $
-
-$3,961
-
Form type
-
4
-
Date filed
-
1/3/2024, 04:35 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GBIO |
Common Stock |
Sale |
-$3.96K |
-2.45K |
-29.55% |
$1.62 |
5.83K |
Jan 2, 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GBIO |
Stock Option (right to buy) |
Award |
$0 |
+161K |
|
$0.00 |
161K |
Jan 2, 2024 |
Common Stock |
161K |
$1.86 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: